Skip to main content

Table 1 Patient's baseline and clinical characteristics

From: Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial

 

Taurolidine group

n = 60

Control group n = 60

p

Age (years)

66.9 (26.4–87.1)

64.5 (22.8–80.8)

0.08

Sex (male/female)

37 (61.7%)/23 (38.3%)

35 (58.3%)/25 (41.7%)

-

Height

170 (7.7)

171 (8.8)

0.76

Weight

74.2 (13.7)

74.2 (11.8)

0.92

Type of cancer

 

n = 60

 

n = 60

 

   Colon

48.3%

29

46.7%

28

 

   Gastric

43.3%

26

43.3%

26

 

   Pancreatic

8.3%

5

10%

6

 

UICC histopathological staging

     

   Colon cancer

 

29

 

28

 

   I

 

8

 

9

 

   II

 

8

 

9

 

   III

 

13

 

10

 

   Gastric cancer

 

26

 

26

 

   IA

 

4

 

5

 

   IB

 

6

 

7

 

   II

 

8

 

5

 

   IIIA

 

5

 

6

 

   IIIB

 

3

 

3

 

   Pancreatic cancer

 

5

 

6

 

   I

   

2

 

   II

 

2

 

2

 

   III

 

3

 

2

 

ASA classification (all patients)

     

   I

23.3%

14

23.3%

14

 

   II

38.3%

23

38.3%

23

 

   III

38.3%

23

38.3%

23

 

Risk factors

 

32

 

24

 

   Arterial hypertension

33.3%

20

26.6%

16

 

   Chronic obstructive lung disease

1.6%

1

5%

3

 

   Diabetes mellitus

13.3%

8

6.6%

4

 

   Nephropathy

5%

3

1.6%

1

 

Tumour location

     

Colon:

     

   Caecum

   

1

 

   Ascending colon

 

5

 

3

 

   Transverse colon

 

3

 

6

 

   Descending colon

 

2

 

3

 

   Sigmoid colon

 

5

 

5

 

   Rectum

 

14

 

10

 

Stomach:

     

   Gastric cardia

 

5

 

3

 

   Gastric fundus

 

4

 

6

 

   Gastric body

 

6

 

9

 

   Gastric antrum

 

11

 

8

 

Pancreas:

     

   Pancreatic head

 

5

 

6

 

Intervention

     

   Right colectomy

 

4

 

4

 

   Extended right colectomy

 

2

 

1

 

   Left colectomy

 

2

 

6

 

   Extended left colectomy

 

1

 

2

 

   Sigmoidectomy

 

5

 

4

 

   Rectum resection

 

10

 

9

 

   Abdominoperineal resection

 

4

 

1

 

   Subtotal colectomy

 

1

 

1

 

   Total gastrectomy

 

14

 

19

 

   Total gastrectomy + splenectomy

 

3

 

2

 

   Subtotal (3/4) gastrectomy

 

8

 

5

 

   Distal esophageal resection

 

1

   

   Pancreatic head resection (Kausch-Whipple' resection)

 

1

 

3

 

   Pylorus-preserving duodenopancreatectomy

 

4

 

3

 
  1. Values are median (range), mean (standard deviation) or number, esophagectomy: adenocarcinoma of the cardia (Type Siewert I)